1. Association of the FGF4L2 retrogene with fibrocartilaginous embolic myelopathy in dogs.
- Author
-
Embersics, Colleen, Batcher, Kevin, Boudreau, Elizabeth, Church, Molly, Miller, Andrew, Platt, Simon, Koehler, Jey, Olby, Natasha, Rossmeisl, John, Rissi, Daniel, Grahn, Robert, Donner, Jonas, Bannasch, Danika, and Dickinson, Peter
- Subjects
FCE ,canine ,chondrodystrophy ,fibroblast growth factor ,Animals ,Dogs ,Cartilage Diseases ,Dog Diseases ,Embolism ,Genotype ,Spinal Cord Diseases - Abstract
BACKGROUND: Fibrocartilaginous embolic myelopathy (FCE) is a well-documented condition in dogs although rarely reported in chondrodystrophic breeds. Genetic associations have not been defined. OBJECTIVES: Define the association of the chondrodystrophy-associated FGF4L2 retrogene with histopathologically confirmed cases of FCE. ANIMALS: Ninety-eight dogs with a histopathologic diagnosis of FCE. METHODS: Retrospective multicenter study. Dogs were genotyped for the FGF4L2 and FGF4L1 retrogenes using DNA extracted from formalin-fixed, paraffin-embedded tissue. Associations between breed, FCE and retrogene status were investigated with reference to a hospital population and known breed and general population allele frequencies. RESULTS: FGF4L2 genotype was defined in 89 FCE cases. Fibrocartilaginous embolic myelopathy was present in 22 dogs from FGF4L2-segregating breeds with allele frequencies of ≥5%; however, all dogs were wild type. Two Labrador retrievers with FCE carried FGF4L2 alleles. Frequency of the FGF4L2 allele was significantly (P
- Published
- 2024